EUVIMEDEUVIMED entdecken
Open Access

Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction — Worldwide, 2018–2022

Molly Hancuh, Jenny Walldorf, Anna A Minta, Carol Tevi-Benissan, Kira A Christian, Yoann Nedelec, Kristen Heitzinger, Matthew Mikoleit, Amanda Tiffany, Adwoa D Bentsi-Enchill, Lucy Breakwell

MMWR. Morbidity and Mortality Weekly Report · 17.02.2023 · 72 (7) · 171-176

DOI: 10.15585/mmwr.mm7207a2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, online erschienen am 17.02.2023. Verfasst von Molly Hancuh und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Typhoid Fever, Typhoid-Paratyphoid Vaccines, Anti-Infective Agents. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Typhoid fever, an acute febrile illness caused by Salmonella enterica serovar Typhi (S. Typhi), is endemic in many low- and middle-income countries† (1). In 2015, an estimated 11-21 million typhoid fever cases and 148,000-161,000 associated deaths occurred worldwide (2). Effective prevention strategies include improved access to and use of infrastructure supporting safe water, sanitation, and hygiene (WASH); health education; and vaccination (1). The World Health Organization (WHO) recommends programmatic use of typhoid conjugate vaccines for typhoid fever control and prioritization of vaccine introduction in countries with the highest typhoid fever incidence or high prevalence of antimicrobial-resistant S. Typhi (1). This report describes typhoid fever surveillance, incidence estimates, and the status of typhoid conjugate vaccine introduction during 2018-2022. Because routine surveillance for typhoid fever has low sensitivity, population-based studies have guided estimates of case counts and incidence in 10 countries since 2016 (3-6). In 2019, an updated modeling study estimated that 9.2 million (95% CI = 5.9-14.1) typhoid fever cases and 110,000 (95% CI = 53,000-191,000) deaths occurred worldwide, with the highest estimated incidence in the WHO South-East Asian (306 cases per 100,000 persons), Eastern Mediterranean (187), and African (111) regions (7). Since 2018, five countries (Liberia, Nepal, Pakistan, Samoa [based on self-assessment], and Zimbabwe) with estimated high typhoid fever incidence (≥100 cases per 100,000 population per year) (8), high antimicrobial resistance prevalence, or recent outbreaks introduced typhoid conjugate vaccines into their routine immunization programs (2). To guide vaccine introduction decisions, countries should consider all available information, including surveillance of laboratory-confirmed cases, population-based and modeling studies, and outbreak reports. Establishing and strengthening typhoid fever surveillance will be important to measure vaccine impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Typhoid FeverTyphoid-Paratyphoid VaccinesAnti-Infective AgentsHumansVaccines, ConjugateIncidence

Substanzen

Vaccines, ConjugateTyphoid-Paratyphoid VaccinesAnti-Infective Agents

Zitieren

APA

Hancuh, M., Walldorf, J., Minta, A. A., Tevi-Benissan, C., Christian, K. A., Nedelec, Y., Heitzinger, K., Mikoleit, M., Tiffany, A., Bentsi-Enchill, A. D., & Breakwell, L. (2023). Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction — Worldwide, 2018–2022. MMWR. Morbidity and Mortality Weekly Report, 72(7), 171-176. https://doi.org/10.15585/mmwr.mm7207a2

Vancouver

Hancuh M, Walldorf J, Minta AA, Tevi-Benissan C, Christian KA, Nedelec Y, et al. Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction — Worldwide, 2018–2022. MMWR. Morbidity and Mortality Weekly Report. 2023;72(7):171-176. doi:10.15585/mmwr.mm7207a2

BibTeX
@article{Hancuh2023,
  author = {Hancuh, Molly and Walldorf, Jenny and Minta, Anna A and Tevi-Benissan, Carol and Christian, Kira A and Nedelec, Yoann and Heitzinger, Kristen and Mikoleit, Matthew and Tiffany, Amanda and Bentsi-Enchill, Adwoa D and Breakwell, Lucy},
  title = {Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction — Worldwide, 2018–2022},
  journal = {MMWR. Morbidity and Mortality Weekly Report},
  year = {2023},
  volume = {72},
  number = {7},
  pages = {171--176},
  doi = {10.15585/mmwr.mm7207a2}
}
Kostenlos starten →